Author:
Viola Giampietro,Cecconet Laura,Leszl Anna,Basso Giuseppe,Brun Paola,Salvador Alessia,Dall’Acqua Francesco,Diana Patrizia,Barraja Paola,Cirrincione Girolamo
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference47 articles.
1. Bleehen NM, Newlands ES, Lee SM et al (1995) Cancer research campaign phase II trial of temozolomide in metastatic melanoma. J Clin Oncol 13:910–913
2. O’Reilly SM, Newlands ES, Glaser MG et al (1993) Temozolomide: a new oral cytotoxic chemotherapeutic agent with promising activity against primary brain tumors. Eur J Cancer 29A:940–942
3. Newlands ES, Blackledge GRP, Slack JA et al (1992) Phase I trial of temozolomide (CCRG 81045: M&B 39831: NSC 362856). Br J Cancer 65:287–291
4. Newlands ES, Stevens MFG, Wedge SR et al (1997) Temozolomide: a review of its discovery, chemical properties, pre-clinical development and clinical trials. Cancer Treat Rep 23:35–61
5. Catapano CV, Broggini M, Erba E et al (1987) In vitro and in vivo Methazolastone-induced DNA damage and repair in L-1210 leukemia sensitive and resistano to chloroethylnitrosoureas. Cancer Res 47:4884–4889
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献